Navigation Links
MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
Date:10/16/2007

WELLESLEY HILLS, Mass., Oct. 16 /PRNewswire-FirstCall/ -- MacroChem (OTC Bulletin Board: MACM) will participate in the PIPEs Conference 2007 to be held at the Hilton New York on October 18 and 19. The company will have an exhibit table, located outside the Sutton Room, throughout each day of the conference. MacroChem's President and Chief Executive Officer, Robert J. DeLuccia, will provide a company overview, including discussion about MacroChem's lead product, EcoNail(R), which is currently in a fully enrolled Phase 2 clinical trial. DeLuccia will also discuss MacroChem's newly acquired rights to pexiganan, a novel, topical anti-infective drug for treatment of diabetic foot infection (DFI), and its recent preferred stock conversion and private placement.

The PIPEs Conference will be a mix of education and networking with active investors in the small cap equity market. Two full days of programming will provide insight on industry developments from experts in the field, as well as networking opportunities with institutional investors, investment bankers, corporate attorneys, company executives, financial analysts, and media representatives from around the globe.

About MacroChem

MacroChem Corporation is a specialty pharmaceutical company that develops and seeks to commercialize pharmaceutical products. Our lead product candidate is EcoNail, a topically applied SEPA-based econazole lacquer for the treatment of onychomycosis, a condition commonly known as nail fungus. We recently acquired exclusive worldwide license rights to pexiganan, a novel topical anti-infective for the treatment of diabetic foot infection, which has already completed two Phase 3 trials. Our other clinical stage product candidate, Opterone(R), is a topically applied SEPA-based testosterone cream designed to treat male hypogonadism. Our pipeline of clinical-stage and early-stage product candidates is based on our SEPA(R), MacroDerm(TM) and DermaPass(TM) drug delivery technologies. For more information visit our website, http://www.macrochem.com.

Forward-Looking Statements

With the exception of historical information contained in this press release, the matters described herein are forward-looking statements that involve risks and uncertainties. MacroChem's actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed or referred to in the section entitled "Risk Factors" in MacroChem's Annual Report on Form 10-K, as well as those discussed elsewhere therein, and include, without limitation, risks regarding product development, the timing and results of clinical trials, the regulatory approval process, capital requirements, financial condition, patent protection and dependence on third parties for development and licensing arrangements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. MacroChem undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. For more information visit our website, http://www.macrochem.com.

Contact:

MacroChem: Bernard Patriacca -- VP/CFO

bpatriacca@macrochem.com, (781) 489-7310

Investor Relations: The Investor Relations Group, Inc.

Christine Berni / Joseph Triunfo, (212) 825-3210

cberni@investorrelationsgroup.com, jtriunfo@investorrelationsgroup.com

Media:

Bill Douglass / Michaela Heller, (212) 825-3210

bdouglass@investorrelationsgroup.com

mheller@investorrelationsgroup.com


'/>"/>
SOURCE MacroChem Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruker Participates in Dutch Funded Super Microscope Project
2. Digital Healthcare Conference 2007: Mounting obstacles for health IT
3. Biomedical engineering conference invites manufacturers
4. Conference to address small town development
5. Wisconsin to host SBIR Conference
6. Gaming conference explores interactive media in learning
7. Digital Healthcare Conference starts on a realistic note
8. Digital Healthcare Conference marks Wisconsins Healthcare IT Week
9. Third coast of biotechnology makes strong showing at VC conference
10. Why companies dont get invited to the DEMO conference
11. Giuliani will keynote RedPrairie Corporations user conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... While things have been quiet for EcoloCap over the ... a new outlook for the future. As a continued effort to bring innovative ... retirement of Mr. Siegel as CEO. With the new adjustments in management, EcoloCap has ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... and a winner of the 43North Startup Competition, has truly taken their cancer ... spacecraft delivered Oncolinx’s innovative cancer experiments from Cape Canaveral to the International Space ...
(Date:4/27/2017)... SEATTLE, WA (PRWEB) , ... April 27, 2017 ... ... a revolutionary, cloud-based and secure electronic informed consent (eConsent) solution that simplifies research ... the technology and consulting division of Quorum, Q Consent™ is the first ...
(Date:4/27/2017)... Monterey, California (PRWEB) , ... April 27, 2017 ... ... a new infographic explaining why mass flow controllers based on capillary thermal mass ... for industrial gas mass flow control applications. Over 80% of all industrial ...
Breaking Biology Technology:
(Date:4/18/2017)... 18, 2017  Socionext Inc., a global expert in SoC-based imaging ... server, the M820, which features the company,s hybrid codec technology. A ... Tera Probe, Inc., will be showcased during the upcoming Medtec Japan ... at the Las Vegas Convention Center April ... Click here for ...
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):